MeVPaMe1 (R), n=1 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: ACh

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - - 117.0 625.0 1104.0 66.0 6.0 1918
1 - - - - - 3.0 52.0 48.0 2.0 - 105
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - 73.0 73
Pre - - - - - - 56.0 56
  AME
0 81
1 13
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 343
1 791

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 1918

Number of pre synapses: 105

Number of output connections: 164

Coverage factor: 1.0

Columnar completeness: 0.53

Area completeness: 0.89

Cell size (columns): 474

Lobula

Number of post synapses: 73

Number of pre synapses: 56

Number of output connections: 171

Coverage factor: 1.0

Columnar completeness: 0.04

Area completeness: 0.25

Cell size (columns): 32

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVPaMe1 (R) % % cumu.
0 Mi4 (R) GABA 477 477.0 22.3% 22.3%
1 Tm4 (R) ACh 188 188.0 8.8% 31.1%
2 Tm5Y (R) ACh 140 140.0 6.5% 37.6%
3 Cm6 (R) GABA 114 114.0 5.3% 43.0%
4 MeVPMe11 (L) Glu 110 110.0 5.1% 48.1%
5 Tm16 (R) ACh 85 85.0 4.0% 52.1%
6 MeLo6 (R) ACh 70 70.0 3.3% 55.4%
7 TmY21 (R) ACh 69 69.0 3.2% 58.6%
8 LoVP96 (R) Glu 64 64.0 3.0% 61.6%
9 MeLo7 (R) ACh 59 59.0 2.8% 64.3%
10 Cm3 (R) GABA 52 52.0 2.4% 66.8%
11 MeVP62 (R) ACh 39 39.0 1.8% 68.6%
12 MeLo3b (R) ACh 37 37.0 1.7% 70.3%
13 TmY10 (R) ACh 23 23.0 1.1% 71.4%
14 MeVPMe3 (L) Glu 22 22.0 1.0% 72.4%
15 MeVPMe4 (L) Glu 21 21.0 1.0% 73.4%
16 aMe2 (R) Glu 20 20.0 0.9% 74.3%
17 MeVC11 (L) ACh 20 20.0 0.9% 75.3%
18 LPT51 (R) Glu 19 19.0 0.9% 76.2%
19 Cm8 (R) GABA 18 18.0 0.8% 77.0%
20 MeVPaMe2 (L) Glu 18 18.0 0.8% 77.8%
21 MeVC2 (L) ACh 17 17.0 0.8% 78.6%
22 Pm2a (R) GABA 15 15.0 0.7% 79.3%
23 aMe9 (R) ACh 14 14.0 0.7% 80.0%
24 MeLo1 (R) ACh 14 14.0 0.7% 80.6%
25 Cm4 (R) Glu 13 13.0 0.6% 81.3%
26 TmY13 (R) ACh 13 13.0 0.6% 81.9%
27 TmY15 (R) GABA 13 13.0 0.6% 82.5%
28 MeVC9 (L) ACh 12 12.0 0.6% 83.0%
29 MeVP14 (R) ACh 11 11.0 0.5% 83.5%
30 Tm20 (R) ACh 11 11.0 0.5% 84.1%
31 Tm36 (R) ACh 11 11.0 0.5% 84.6%
32 Tm39 (R) ACh 11 11.0 0.5% 85.1%
33 MeTu4c (R) ACh 10 10.0 0.5% 85.6%
34 MeVC4a (L) ACh 10 10.0 0.5% 86.0%
35 Tm37 (R) Glu 10 10.0 0.5% 86.5%
36 MeLo3a (R) ACh 9 9.0 0.4% 86.9%
37 TmY17 (R) ACh 8 8.0 0.4% 87.3%
38 TmY19a (R) GABA 8 8.0 0.4% 87.7%
39 aMe6b (R) ACh 7 7.0 0.3% 88.0%
40 Cm5 (R) GABA 7 7.0 0.3% 88.3%
41 DNpe053 (R) ACh 7 7.0 0.3% 88.6%
42 MeVP29 (R) ACh 7 7.0 0.3% 89.0%
43 MeVPMe2 (R) Glu 7 7.0 0.3% 89.3%
44 Mi16 (R) GABA 7 7.0 0.3% 89.6%
45 Mi17 (R) GABA 7 7.0 0.3% 89.9%
46 TmY5a (R) Glu 7 7.0 0.3% 90.3%
47 MeVP4 (R) ACh 6 6.0 0.3% 90.6%
48 MeVP6 (R) Glu 6 6.0 0.3% 90.8%
49 Mi15 (R) ACh 6 6.0 0.3% 91.1%
50 Tm32 (R) Glu 6 6.0 0.3% 91.4%
51 Tm6 (R) ACh 6 6.0 0.3% 91.7%
52 aMe1 (R) GABA 5 5.0 0.2% 91.9%
53 Dm-DRA1 (R) Glu 5 5.0 0.2% 92.1%
54 Mi9 (R) Glu 5 5.0 0.2% 92.4%
55 Cm29 (R) GABA 4 4.0 0.2% 92.6%
56 Cm9 (R) Glu 4 4.0 0.2% 92.8%
57 MeTu4f (R) ACh 4 4.0 0.2% 92.9%
58 MeVC20 (R) Glu 4 4.0 0.2% 93.1%
59 MeVP15 (R) ACh 4 4.0 0.2% 93.3%
60 MeVPMe5 (L) Glu 4 4.0 0.2% 93.5%
61 Pm4 (R) GABA 4 4.0 0.2% 93.7%
62 TmY18 (R) ACh 4 4.0 0.2% 93.9%
63 aMe9 (L) ACh 3 3.0 0.1% 94.0%
64 DNpe053 (L) ACh 3 3.0 0.1% 94.2%
65 MeTu4a (R) ACh 3 3.0 0.1% 94.3%
66 MeVC4b (L) ACh 3 3.0 0.1% 94.4%
67 MeVP11 (R) ACh 3 3.0 0.1% 94.6%
68 MeVP3 (R) ACh 3 3.0 0.1% 94.7%
69 Tm34 (R) Glu 3 3.0 0.1% 94.9%
70 TmY16 (R) Glu 3 3.0 0.1% 95.0%
71 5-HTPMPV03 (L) 5HT 2 2.0 0.1% 95.1%
72 aMe10 (L) ACh 2 2.0 0.1% 95.2%
73 aMe5 (R) ACh 2 2.0 0.1% 95.3%
74 Cm15 (R) GABA 2 2.0 0.1% 95.4%
75 Cm16 (R) Glu 2 2.0 0.1% 95.5%
76 Cm25 (R) Glu 2 2.0 0.1% 95.6%
77 Cm34 (R) Glu 2 2.0 0.1% 95.7%
78 Cm7 (R) Glu 2 2.0 0.1% 95.7%
79 Lat1 (R) unclear 2 2.0 0.1% 95.8%
80 LPT54 (R) ACh 2 2.0 0.1% 95.9%
81 MeLo10 (R) Glu 2 2.0 0.1% 96.0%
82 MeLo4 (R) ACh 2 2.0 0.1% 96.1%
83 MeLo5 (R) ACh 2 2.0 0.1% 96.2%
84 MeLo9 (R) Glu 2 2.0 0.1% 96.3%
85 MeTu1 (R) ACh 2 2.0 0.1% 96.4%
86 MeVC10 (L) ACh 2 2.0 0.1% 96.5%
87 MeVP45 (R) ACh 2 2.0 0.1% 96.6%
88 MeVP8 (R) ACh 2 2.0 0.1% 96.7%
89 MeVPMe6 (L) Glu 2 2.0 0.1% 96.8%
90 Mi10 (R) ACh 2 2.0 0.1% 96.9%
91 OLVC4 (L) unclear 2 2.0 0.1% 97.0%
92 OLVC5 (R) ACh 2 2.0 0.1% 97.1%
93 Pm12 (R) Glu 2 2.0 0.1% 97.1%
94 Pm8 (R) GABA 2 2.0 0.1% 97.2%
95 Tm3 (R) ACh 2 2.0 0.1% 97.3%
96 Tm33 (R) ACh 2 2.0 0.1% 97.4%
97 Y3 (R) ACh 2 2.0 0.1% 97.5%
98 5-HTPMPV03 (R) 5HT 1 1.0 0.0% 97.6%
99 5thsLNv_LNd6 (R) ACh 1 1.0 0.0% 97.6%
100 aMe13 (R) unclear 1 1.0 0.0% 97.7%
101 aMe17a (R) Glu 1 1.0 0.0% 97.7%
102 aMe3 (R) Glu 1 1.0 0.0% 97.8%
103 Cm10 (R) GABA 1 1.0 0.0% 97.8%
104 Cm20 (R) GABA 1 1.0 0.0% 97.8%
105 Cm35 (R) GABA 1 1.0 0.0% 97.9%
106 Dm8a (R) Glu 1 1.0 0.0% 97.9%
107 Dm8b (R) Glu 1 1.0 0.0% 98.0%
108 DN1a (R) unclear 1 1.0 0.0% 98.0%
109 l-LNv (L) unclear 1 1.0 0.0% 98.1%
110 Lat3 (R) unclear 1 1.0 0.0% 98.1%
111 LC13 (R) ACh 1 1.0 0.0% 98.2%
112 Li20 (R) Glu 1 1.0 0.0% 98.2%
113 LoVCLo3 (L) OA 1 1.0 0.0% 98.3%
114 LoVP46 (R) Glu 1 1.0 0.0% 98.3%
115 LT52 (R) Glu 1 1.0 0.0% 98.4%
116 LT68 (R) Glu 1 1.0 0.0% 98.4%
117 MeLo11 (R) Glu 1 1.0 0.0% 98.5%
118 MeLo12 (R) Glu 1 1.0 0.0% 98.5%
119 MeLo13 (R) Glu 1 1.0 0.0% 98.6%
120 MeTu2a (R) ACh 1 1.0 0.0% 98.6%
121 MeTu4b (R) ACh 1 1.0 0.0% 98.6%
122 MeTu4e (R) ACh 1 1.0 0.0% 98.7%
123 MeVC22 (R) Glu 1 1.0 0.0% 98.7%
124 MeVC27 (L) unclear 1 1.0 0.0% 98.8%
125 MeVC5 (L) ACh 1 1.0 0.0% 98.8%
126 MeVP1 (R) ACh 1 1.0 0.0% 98.9%
127 MeVP2 (R) ACh 1 1.0 0.0% 98.9%
128 MeVP20 (R) unclear 1 1.0 0.0% 99.0%
129 MeVP32 (R) ACh 1 1.0 0.0% 99.0%
130 MeVP57 (R) unclear 1 1.0 0.0% 99.1%
131 MeVP63 (R) GABA 1 1.0 0.0% 99.1%
132 MeVP7 (R) ACh 1 1.0 0.0% 99.2%
133 MeVP9 (R) ACh 1 1.0 0.0% 99.2%
134 MeVPaMe1 (L) ACh 1 1.0 0.0% 99.3%
135 MeVPMe1 (L) Glu 1 1.0 0.0% 99.3%
136 MeVPMe10 (L) Glu 1 1.0 0.0% 99.3%
137 Mi1 (R) ACh 1 1.0 0.0% 99.4%
138 OA-AL2i3 (R) OA 1 1.0 0.0% 99.4%
139 OA-AL2i4 (R) OA 1 1.0 0.0% 99.5%
140 OA-ASM1 (R) OA 1 1.0 0.0% 99.5%
141 Pm9 (R) GABA 1 1.0 0.0% 99.6%
142 T2a (R) ACh 1 1.0 0.0% 99.6%
143 Tm30 (R) GABA 1 1.0 0.0% 99.7%
144 Tm35 (R) Glu 1 1.0 0.0% 99.7%
145 Tm40 (R) ACh 1 1.0 0.0% 99.8%
146 Tm5c (R) Glu 1 1.0 0.0% 99.8%
147 TmY14 (R) Glu 1 1.0 0.0% 99.9%
148 TmY3 (R) ACh 1 1.0 0.0% 99.9%
149 TmY4 (R) ACh 1 1.0 0.0% 100.0%
150 TmY9a (R) ACh 1 1.0 0.0% 100.0%

Outputs

  instance NT total connections connections /#MeVPaMe1 (R) % % cumu.
0 aMe17c (R) Glu 102 102.0 11.6% 11.6%
1 MeVC22 (R) Glu 100 100.0 11.4% 23.0%
2 LoVP96 (R) Glu 69 69.0 7.9% 30.9%
3 aMe17e (R) Glu 59 59.0 6.7% 37.6%
4 DNp27 (R) unclear 51 51.0 5.8% 43.4%
5 CL125 (R) unclear 36 36.0 4.1% 47.5%
6 Lawf2 (R) ACh 32 32.0 3.6% 51.1%
7 MeLo8 (R) GABA 32 32.0 3.6% 54.8%
8 LoVP53 (R) ACh 29 29.0 3.3% 58.1%
9 aMe_TBD1 (R) unclear 26 26.0 3.0% 61.0%
10 LoVP100 (R) unclear 25 25.0 2.8% 63.9%
11 MeVC20 (R) Glu 25 25.0 2.8% 66.7%
12 LoVP50 (R) ACh 20 20.0 2.3% 69.0%
13 MeVC21 (R) Glu 19 19.0 2.2% 71.2%
14 MeVC24 (R) Glu 17 17.0 1.9% 73.1%
15 Cm24 (R) Glu 16 16.0 1.8% 74.9%
16 aMe2 (R) Glu 15 15.0 1.7% 76.7%
17 aMe30 (R) Glu 12 12.0 1.4% 78.0%
18 MeVPMe2 (R) Glu 11 11.0 1.3% 79.3%
19 Li35 (R) GABA 10 10.0 1.1% 80.4%
20 LoVP9 (R) unclear 9 9.0 1.0% 81.4%
21 MeVC23 (R) Glu 9 9.0 1.0% 82.5%
22 LT52 (R) Glu 8 8.0 0.9% 83.4%
23 MeLo7 (R) ACh 8 8.0 0.9% 84.3%
24 Tm16 (R) ACh 7 7.0 0.8% 85.1%
25 aMe17a (R) Glu 5 5.0 0.6% 85.6%
26 Lat1 (R) unclear 5 5.0 0.6% 86.2%
27 MeLo1 (R) ACh 5 5.0 0.6% 86.8%
28 SMP217 (R) unclear 5 5.0 0.6% 87.4%
29 Cm7 (R) Glu 4 4.0 0.5% 87.8%
30 MeLo13 (R) Glu 4 4.0 0.5% 88.3%
31 MeVP14 (R) ACh 4 4.0 0.5% 88.7%
32 MeVP53 (R) GABA 4 4.0 0.5% 89.2%
33 MeVP62 (R) ACh 4 4.0 0.5% 89.6%
34 aMe6c (R) Glu 3 3.0 0.3% 90.0%
35 LPT51 (R) Glu 3 3.0 0.3% 90.3%
36 MeLo6 (R) ACh 3 3.0 0.3% 90.7%
37 Mi16 (R) GABA 3 3.0 0.3% 91.0%
38 T2a (R) ACh 3 3.0 0.3% 91.3%
39 aMe25 (R) unclear 2 2.0 0.2% 91.6%
40 aMe5 (R) ACh 2 2.0 0.2% 91.8%
41 aMe9 (R) ACh 2 2.0 0.2% 92.0%
42 Cm5 (R) GABA 2 2.0 0.2% 92.3%
43 DN1a (R) unclear 2 2.0 0.2% 92.5%
44 Li34b (R) GABA 2 2.0 0.2% 92.7%
45 LoVP80 (R) unclear 2 2.0 0.2% 92.9%
46 MeLo3b (R) ACh 2 2.0 0.2% 93.2%
47 MeVP10 (R) ACh 2 2.0 0.2% 93.4%
48 MeVP6 (R) Glu 2 2.0 0.2% 93.6%
49 Mi17 (R) GABA 2 2.0 0.2% 93.8%
50 Pm12 (R) Glu 2 2.0 0.2% 94.1%
51 Pm9 (R) GABA 2 2.0 0.2% 94.3%
52 TmY17 (R) ACh 2 2.0 0.2% 94.5%
53 TmY5a (R) Glu 2 2.0 0.2% 94.8%
54 aMe10 (R) ACh 1 1.0 0.1% 94.9%
55 aMe22 (R) Glu 1 1.0 0.1% 95.0%
56 aMe24 (R) unclear 1 1.0 0.1% 95.1%
57 aMe4 (R) ACh 1 1.0 0.1% 95.2%
58 Cm12 (R) GABA 1 1.0 0.1% 95.3%
59 Cm23 (R) Glu 1 1.0 0.1% 95.4%
60 Cm27 (R) Glu 1 1.0 0.1% 95.6%
61 Cm3 (R) GABA 1 1.0 0.1% 95.7%
62 Cm6 (R) GABA 1 1.0 0.1% 95.8%
63 Cm8 (R) GABA 1 1.0 0.1% 95.9%
64 LC6 (R) ACh 1 1.0 0.1% 96.0%
65 LC9 (R) ACh 1 1.0 0.1% 96.1%
66 Li23 (R) ACh 1 1.0 0.1% 96.2%
67 LoVP104 (R) ACh 1 1.0 0.1% 96.4%
68 LT36 (L) GABA 1 1.0 0.1% 96.5%
69 MeLo10 (R) Glu 1 1.0 0.1% 96.6%
70 MeTu4c (R) ACh 1 1.0 0.1% 96.7%
71 MeVP1 (R) ACh 1 1.0 0.1% 96.8%
72 MeVP12 (R) ACh 1 1.0 0.1% 96.9%
73 MeVP16 (R) Glu 1 1.0 0.1% 97.0%
74 MeVP26 (R) unclear 1 1.0 0.1% 97.2%
75 MeVP29 (R) ACh 1 1.0 0.1% 97.3%
76 MeVP31 (R) ACh 1 1.0 0.1% 97.4%
77 MeVP39 (R) unclear 1 1.0 0.1% 97.5%
78 MeVP9 (R) ACh 1 1.0 0.1% 97.6%
79 MeVPLo1 (R) Glu 1 1.0 0.1% 97.7%
80 MeVPLo2 (L) ACh 1 1.0 0.1% 97.8%
81 MeVPMe1 (R) Glu 1 1.0 0.1% 97.9%
82 MeVPMe11 (L) Glu 1 1.0 0.1% 98.1%
83 MeVPMe3 (L) Glu 1 1.0 0.1% 98.2%
84 Mi13 (R) Glu 1 1.0 0.1% 98.3%
85 Mi19 (R) 5HT 1 1.0 0.1% 98.4%
86 PLP004 (R) unclear 1 1.0 0.1% 98.5%
87 Pm2a (R) GABA 1 1.0 0.1% 98.6%
88 Pm2b (R) GABA 1 1.0 0.1% 98.7%
89 Pm8 (R) GABA 1 1.0 0.1% 98.9%
90 SLP249 (R) unclear 1 1.0 0.1% 99.0%
91 Tm32 (R) Glu 1 1.0 0.1% 99.1%
92 Tm38 (R) ACh 1 1.0 0.1% 99.2%
93 Tm39 (R) ACh 1 1.0 0.1% 99.3%
94 Tm5Y (R) ACh 1 1.0 0.1% 99.4%
95 TmY10 (R) ACh 1 1.0 0.1% 99.5%
96 TmY15 (R) GABA 1 1.0 0.1% 99.7%
97 TmY21 (R) ACh 1 1.0 0.1% 99.8%
98 TmY9a (R) ACh 1 1.0 0.1% 99.9%
99 Y14 (R) Glu 1 1.0 0.1% 100.0%